Lucy Francis

Clinical research fellow in vasculitis
@Cambridge_Uni funded by @ACTcharity.
ST6 in Neph at Addenbrooke’s and Lister.

[Andrew Frankel @AndrewFrankel1]

⚕️ Potassium and RAASi: What to Know

Listen to our latest CKD Podcast as we discuss RAAS and potassium increases.

🎧Listen here: https://t.co/K5ozsNz7rq

[Sian Griffin 🏴󠁧󠁢󠁷󠁬󠁳󠁿 🌻 🇺🇦 🌻 🏳️‍⚧️ @toomuchaltitude]

Absolutely stellar talk by Ben Stewart at #UKKW2024 Raine Award 👏👏👏@ClatworthyLab

[Lucy Francis @Lucy60070347]

Ben receiving the Raine Award at UKKW #UKKW2024 @UKKidney

[Lucy Francis @Lucy60070347]

@claremorlidge kicking off UKKW 2024 in style! #UKKW2024

[Lauren Floyd @DocL_Floyd]

Fabulous talks at this mornings GN focussed oral session 🤩 #ERA24 @Lucy60070347 @Allysonegan1 @smirioglu

[Muthu Vaduganathan @mvaduganathan]

🚨#FLOW: The most anticipated trial of the year now published in @NEJM with #ERA24

Semaglutide 1.0mg once weekly disease modifying with kidney, CV, & mortality benefits in people w T2D+CKD, cementing itself as a new pillar of care.

🧵 on key thoughts 👇🏾

https://t.co/5fbSxPSAMM

[Lucy Francis @Lucy60070347]

Considering there are >3500 patients in the FLOW study with T2DM at high risk of CKD progression and CV events, it is a shame only 4.4% and 4.6% in each arm were of black ethnicity…

[Swapnil Hiremath @hswapnil.medsky.social @hswapnil]

The FLOW trial results are live at @nejm as well

#ERA24

https://t.co/C6DGQf6wVK

Primary composite kidney ✅
CV Death✅
All cause death ✅
GFR slope ✅
First MACE ✅
Kidney specific composite ✅

[Maria Jose Soler @PepaSolerR]

#Flow trial #Era24 bravooooo!!!!👏👏👏👏

[Lucy Francis @Lucy60070347]

Results of the FLOW trial! #ERA24 @ERAkidney

[Lucy Francis @Lucy60070347]

Well that was like watching a movie! Looking to the biodiversity in the world for solutions to problems with human health… @ERAkidney #ERA2024

[Lucy Francis @Lucy60070347]

Really great talk from Claudia Izzi on ADTKD 🧬

[Lucy Francis @Lucy60070347]

Really excited for the next few days at the ERA congress! @ERAkidney #ERA24

[Lucy Francis @Lucy60070347]

It’s been a brilliant couple of days @VasculitisBCN24 !

[Silke R Brix @BrixSilke]

Brilliant start to the day - SFAs reduce inflammation in the murine MPO model - what a great potential for clinical translation! Lovely presented by ⁦@Kim_M_OS⁩ of ⁦@MonashUni⁩ at ⁦@VasculitisBCN24⁩ 👏👏👏

[Lucy Francis @Lucy60070347]

Learning lots on innate and adaptive immunity at the ENRAD training day!

[Sian Griffin 🏴󠁧󠁢󠁷󠁬󠁳󠁿 🌻 🇺🇦 🌻 🏳️‍⚧️ @toomuchaltitude]

Exhilarating! Superb line-up, congratulations to @Allysonegan1 @IgAN_JBarratt and Rachel Jones for exemplary programme and organisation 👏👏👏

[The UK Kidney Association @UKKidney]

🚨 Updated guidelines alert! The UKKA’s latest update on Treatment of Acute Hyperkalaemia in Adults brings crucial changes. From IV calcium salt rates to novel potassium binder use for moderate & severe cases, these changes are reshaping care standards.
➡️ https://t.co/zqMI66vWdd

[Hans-Joachim Anders @hjanders_hans]

Now open access in @NDTsocial

The new generation of B cell-targeting therapies for the treatment of autoimmune kidney diseases

▶️https://t.co/e9yDq4U2nF